|
US - Novartis AG acquired the pulmonary business of Nektar Therapeutics, a manufacturer of biopharmaceuticals, for $### mil in cash. The transaction was to include certain dry powder and liquid pulmonary formulation and manufacturing assets, including capital equipment and manufacturing facility…
|
| Credit & Investment Research |
|
|